e-Drug3D

435

DANAZOL


INN
DANAZOL

cas 17230-88-5
CLASS

GENITO
ANTERIOR PITUITARY SUPPRESSANT
NUCLEAR RECEPTOR ANTAGONISTS

ROUTE (list)

ORAL

ATC code

G03XA01

PK parameters

Tmax 4 HOUR
Cl 727 LITER / HOUR
t1/2 9.7 HOUR

Solubility

INSOLUBLE IN WATER


Target

TARGET ESTROGEN RECEPTOR
PROGESTERONE RECEPTOR
ANDROGEN RECEPTOR

PDB
6ULB (SEX HORMONE-BINDING GLOBULIN MUTANT E176K IN COMPLEX WITH DANAZOL)

Ligand code = QA1 (link to the list of PDB complexes)

Download experimental 3D coordinates of QA1 with added hydrogens

DrugCentral

Androgen receptor UNIPROT P10275 AR

Progesterone receptor UNIPROT P06401 PGR

Download SDF file Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol, (17.alpha.)-

Formula:
C22H27NO2

Calculated chemical properties:

MW 337.45
NB_atoms 25
XLogP 4.22
PSA 42.721
NB_HD 1
NB_HA 3
fsp3 0.68
Lipinski(0=no;1=yes) 1

FDA
NDA 071569 (pdf not found) INN (DANAZOL) DANAZOL (AM THERAP) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 017557 (label) INN (DANAZOL) DANOCRINE (SANOFI AVENTIS US) APPROVAL= AP YEAR= 1976 DISCONTINUED
NDA 074582 (pdf not found) INN (DANAZOL) DANAZOL (BARR) APPROVAL= AP YEAR= 1996
NDA 077246 (pdf not found) INN (DANAZOL) DANAZOL (LANNETT CO INC) APPROVAL= AP YEAR= 2005
NDA 078214 (pdf not found) INN (DANAZOL) DANAZOL (LANNETT) APPROVAL= AP YEAR= 2007

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL